loading page

Establishing a video Multidisciplinary Team meeting between Cameroon, Central Africa, and Leeds, UK, childhood cancer services
  • +9
  • Bernard Wirndzem Njodzeka,
  • Glenn Afungchwi,
  • Francine Kouya,
  • Susan Picton,
  • Roly Squire,
  • Brian Jator,
  • Vera Njamshi,
  • Richard Bardin,
  • Peter Hesseling,
  • Rachel Hollis,
  • Ghislain Feudjio,
  • Jessica Morgan
Bernard Wirndzem Njodzeka
Cameroon Baptist Convention Health Service

Corresponding Author:bnjodzeka@gmail.com

Author Profile
Glenn Afungchwi
Mbingo Baptist Hospital
Author Profile
Francine Kouya
Mbingo Baptist Hospital
Author Profile
Susan Picton
Leeds General Infirmary
Author Profile
Roly Squire
St. James University Hospital
Author Profile
Brian Jator
Cameroon Baptist Convention Health Service
Author Profile
Vera Njamshi
Cameroon Baptist Convention Health Board
Author Profile
Richard Bardin
Cameroon Baptist Convention Health Service
Author Profile
Peter Hesseling
Stellenbosch University Faculty of Medicine and Health Sciences
Author Profile
Rachel Hollis
Leeds Children's Hospital
Author Profile
Ghislain Feudjio
Cameroon Baptist Convention Health Service
Author Profile
Jessica Morgan
University of York
Author Profile

Abstract

Abstract Background and aims Multidisciplinary team (MDT) meetings provide a regular, structured meeting of a core group of professionals to provide expert decision-making in individual patient care. We describe our experiences in establishing a virtual pediatric oncology MDT between twinning partners in Cameroon (4 hospitals) and the UK. Methods Monthly video conferencing MDT meetings were established in March 2019, initially using Google meet then using Zoom platforms. Case details were circulated using formal proformas. Standard operating procedures were outlined for the MDT conduct. Results There have been 269 discussions of 201 patients in 21 meetings. Patients have been varied in age (up to 24 years). Eighty-seven (43.3%) patients had NHL, 16 (8.0%) had Wilms tumour, 20 (10.0%) had Acute Lymphoblastic Leukaemia, 19 (9.5%) had Retinoblastoma and 59 (29.4%) had other malignancies. Four of the patients did not have a malignancy. The majority of patients had stage 3 (51, 45.1%) or stage 4 (59, 52.2%). Nine patients had relapsed disease. Core team members reported positive benefits from the MDT, including defining goals of care, shared decision making, professional education and team-building. Conclusions Virtual MDT meetings between geographically dispersed teams are possible and have proved particularly valuable during the COVID-19 pandemic when in-person visits are not permitted. Cancer treatment cannot be done in isolation; the regular MDT meetings have paved the way for informed care through regular consultancy.
29 Sep 2021Submission Checks Completed
29 Sep 2021Assigned to Editor
29 Sep 2021Submitted to Pediatric Blood & Cancer
04 Oct 2021Reviewer(s) Assigned
09 Nov 2021Review(s) Completed, Editorial Evaluation Pending
11 Nov 2021Editorial Decision: Revise Major